Published in Brain on July 01, 2000
Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol (2011) 4.37
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J Peripher Nerv Syst (2011) 2.03
Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain (2009) 1.70
Molecular mechanisms of inherited demyelinating neuropathies. Glia (2008) 1.68
Update on Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep (2011) 1.66
The PMP22 gene and its related diseases. Mol Neurobiol (2012) 1.53
Copy number variations in 6q14.1 and 5q13.2 are associated with alcohol dependence. Alcohol Clin Exp Res (2012) 1.50
Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol (2005) 1.32
Axonal protective effects of the myelin-associated glycoprotein. J Neurosci (2009) 1.29
Determinants of reduced health-related quality of life in pediatric inherited neuropathies. Neurology (2010) 1.23
Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry (2005) 1.15
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics (2009) 1.10
17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population. J Neurol (2005) 1.05
Inherited peripheral neuropathies. Neurol Clin (2013) 1.04
Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation. J Neurosci (2009) 1.04
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. Orphanet J Rare Dis (2014) 1.00
Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol (2004) 0.97
AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy. Mol Ther (2013) 0.96
Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J Neurol (2009) 0.95
Molecular regulators of nerve conduction - Lessons from inherited neuropathies and rodent genetic models. Exp Neurol (2015) 0.94
Stimulation-induced Ca(2+) influx at nodes of Ranvier in mouse peripheral motor axons. J Physiol (2015) 0.94
Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients. Muscle Nerve (2012) 0.93
c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy. Brain (2014) 0.92
PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain (2009) 0.91
Proximal nerve magnetization transfer MRI relates to disability in Charcot-Marie-Tooth diseases. Neurology (2014) 0.90
Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J Neuropathol Exp Neurol (2010) 0.89
Inherited neuropathies. Semin Neurol (2012) 0.89
Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice. Glia (2008) 0.89
How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? Brain Res (2012) 0.87
New insights into the pathophysiology of pes cavus in Charcot-Marie-Tooth disease type 1A duplication. J Neurol (2011) 0.87
Comparison of CMT1A and CMT2: similarities and differences. J Neurol (2006) 0.86
Comparison between clinical disabilities and electrophysiological values in Charcot-Marie-Tooth 1A patients with PMP22 duplication. J Clin Neurol (2012) 0.86
Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain (2012) 0.86
Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease. Muscle Nerve (2009) 0.85
An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease. Neurobiol Dis (2012) 0.82
Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation. J Neurol (2008) 0.82
Amount and intensity of daily living activities in Charcot-Marie-Tooth 1A patients. Brain Behav (2013) 0.81
Charcot-Marie-Tooth disease and intracellular traffic. Prog Neurobiol (2012) 0.81
Gas7-deficient mouse reveals roles in motor function and muscle fiber composition during aging. PLoS One (2012) 0.80
Anterior tibialis CMAP amplitude correlations with impairment in CMT1A. Muscle Nerve (2013) 0.80
Strategy for genetic testing in Charcot-Marie-disease. Acta Myol (2011) 0.80
The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression. Hum Mol Genet (2013) 0.79
Dejerine-Sottas syndrome grown to maturity: overview of genetic and morphological heterogeneity and follow-up of 25 patients. J Anat (2002) 0.79
Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease? J Anat (2002) 0.79
Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry (2006) 0.79
The function of the Periaxin gene during nerve repair in a model of CMT4F. J Anat (2002) 0.79
Clinical progression in Charcot-Marie-Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family. J Neurol (2010) 0.79
Nerve conduction velocity in CMT1A: what else can we tell? Eur J Neurol (2016) 0.78
A novel system to accelerate the progression of nerve degeneration in transgenic mouse models of neuropathies. Exp Neurol (2012) 0.78
Foot pad skin biopsy in mouse models of hereditary neuropathy. Glia (2010) 0.78
Auditory nerve is affected in one of two different point mutations of the neurofilament light gene. Clin Neurophysiol (2007) 0.78
Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome. Epigenetics (2016) 0.78
Respiratory dysfunction in Charcot-Marie-Tooth disease type 1A. J Neurol (2015) 0.77
A WHEP Domain Regulates the Dynamic Structure and Activity of Caenorhabditis elegans Glycyl-tRNA Synthetase. J Biol Chem (2016) 0.77
Coexistent Charcot-Marie-Tooth type 1A and type 2 diabetes mellitus neuropathies in a Chinese family. Neural Regen Res (2015) 0.77
Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy. J Neuropathol Exp Neurol (2016) 0.77
Evolution of Charcot-Marie-Tooth disease type 1A duplication: a 2-year clinico-electrophysiological and lower-limb muscle MRI longitudinal study. J Neurol (2014) 0.77
In Vivo Confocal Microscopy of the Human Cornea in the Assessment of Peripheral Neuropathy and Systemic Diseases. Biomed Res Int (2015) 0.77
Small nerve fiber involvement in CMT1A. Neurology (2014) 0.76
Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy. Neural Plast (2012) 0.76
Evaluation of dermal myelinated nerve fibers in diabetes mellitus. J Peripher Nerv Syst (2013) 0.76
Hip dysplasia is more severe in Charcot-Marie-Tooth disease than in developmental dysplasia of the hip. Clin Orthop Relat Res (2014) 0.75
Electrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and charcot-marie-tooth type 1: dispersion and correlation analysis. J Phys Ther Sci (2013) 0.75
Rapid genetic screening of Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies patients. Neural Regen Res (2012) 0.75
Foot deformity in charcot marie tooth disease according to disease severity. Ann Rehabil Med (2011) 0.75
Axonal domain disorganization in Caspr1 and Caspr2 mutant myelinated axons affects neuromuscular junction integrity, leading to muscle atrophy. J Neurosci Res (2017) 0.75
Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach. J Multidiscip Healthc (2016) 0.75
Neurological associations in auditory neuropathy spectrum disorder: Results from a tertiary hospital in South India. Ann Indian Acad Neurol (2015) 0.75
A case report of hereditary neuropathy with liability to pressure palsies accompanied by type 2 diabetes mellitus and psoriasis. Medicine (Baltimore) (2017) 0.75
Anatomical distributional defects in mutant genes associated with dominant intermediate Charcot-Marie-Tooth disease type C in an adenovirus-mediated mouse model. Neural Regen Res (2017) 0.75
Hand weakness in Charcot-Marie-Tooth disease 1X. Neuromuscul Disord (2012) 0.75
Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation. J Biol Chem (2015) 0.75
Caveats in the Established Understanding of CMT1A. Ann Clin Transl Neurol (2017) 0.75
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet (1997) 10.93
CARBOHYDRATE METABOLISM IN ADDISON'S DISEASE. J Clin Invest (1940) 9.89
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science (1997) 6.00
Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science (2001) 5.22
Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med (1985) 4.00
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61
THE EFFECT OF 17-HYDROXYCORTICOSTERONE AND RELATED ADRENAL CORTICAL STEROIDS ON SODIUM AND CHLORIDE EXCRETION. Science (1941) 3.45
Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology (2005) 3.44
Triggering myocardial infarction by marijuana. Circulation (2001) 3.36
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest (1984) 3.26
Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol (1983) 3.18
Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci U S A (1980) 3.18
Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) Am J Med Genet (1996) 3.17
Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat (2001) 3.07
Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A (1980) 2.94
Molecular genetics of human blue cone monochromacy. Science (1989) 2.92
Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum Mutat (2003) 2.75
Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet (1994) 2.72
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature (1992) 2.64
Alternative splicing accounts for the four forms of myelin basic protein. Cell (1985) 2.61
Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology (2012) 2.56
Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet (2000) 2.53
Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. Biochem Biophys Res Commun (1980) 2.49
Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds. Nature (1981) 2.41
Human cDNA clones for four species of G alpha s signal transduction protein. Proc Natl Acad Sci U S A (1986) 2.38
Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem (1981) 2.37
Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet (1998) 2.31
Bardet-Biedl syndrome is linked to DNA markers on chromosome 11q and is genetically heterogeneous. Nat Genet (1994) 2.26
Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet (2001) 2.19
Docking and scoring--theoretically easy, practically impossible? Curr Med Chem (2006) 2.18
Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci U S A (1984) 2.06
Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet (1998) 2.01
Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet (1995) 1.95
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Definition of the hyperventilation syndrome. Bull Eur Physiopathol Respir (1986) 1.91
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A (1983) 1.91
Bronchoconstrictor effects of leukotriene C in humans. Science (1982) 1.91
Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1. Am J Med Genet A (2004) 1.90
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. Mol Cell Biol (1990) 1.89
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2001) 1.88
Nucleotide sequence analysis of the purEK operon encoding 5'-phosphoribosyl-5-aminoimidazole carboxylase of Escherichia coli K-12. J Bacteriol (1989) 1.88
The Hox-1.3 homeo box protein is a sequence-specific DNA-binding phosphoprotein. Genes Dev (1989) 1.83
Isolation of anonymous DNA sequences from within a submicroscopic X chromosomal deletion in a patient with choroideremia, deafness, and mental retardation. Proc Natl Acad Sci U S A (1987) 1.83
Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci U S A (1980) 1.82
Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1999) 1.81
CMT1X phenotypes represent loss of GJB1 gene function. Neurology (2007) 1.77
Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol (1981) 1.76
'Take the stairs instead of the escalator': effect of environmental prompts on community stair use and implications for a national 'Small Steps' campaign. Obes Rev (2006) 1.73
The relationship between asthma admission rates, routes of admission, and socioeconomic deprivation. Eur Respir J (1996) 1.72
Two-dimensional time-resolved X-ray diffraction studies of live isometrically contracting frog sartorius muscle. J Muscle Res Cell Motil (1993) 1.71
Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology (2008) 1.70
Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. Hum Mol Genet (2000) 1.70
Is asthma treatment affordable in developing countries? Thorax (1997) 1.70
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry (2009) 1.68
Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest (1984) 1.65
Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood (1996) 1.64
Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax (1983) 1.64
Identification of three forms of human myelin basic protein by cDNA cloning. Proc Natl Acad Sci U S A (1986) 1.64
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology (1982) 1.63
The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res (1999) 1.61
Dosage and delivery of nebulised beta agonists in hospital. Thorax (1983) 1.59
Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B. Neurology (2006) 1.59
White matter changes associated with deletions of the long arm of chromosome 18 (18q- syndrome): a dysmyelinating disorder? AJNR Am J Neuroradiol (1997) 1.58
Secretion in dissociated human pulmonary mast cells. Evidence for solubilization of granule contents before discharge. J Cell Biol (1980) 1.57
Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet (1988) 1.57
IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med (1983) 1.56
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. J Biol Chem (1984) 1.56
Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology (1981) 1.55
Increasing informed uptake and non-uptake of screening: evidence from a systematic review. Health Expect (2001) 1.54
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet (2001) 1.54
Maternal uniparental isodisomy of chromosome 14: association with autosomal recessive rod monochromacy. Am J Hum Genet (1992) 1.52
Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet (2001) 1.52
British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax (2011) 1.51
Multiple endocrine syndrome type IIb in early childhood. Cancer (1991) 1.48
Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet (1993) 1.47
Synthesis and release of leukotriene C4 by human eosinophils. J Immunol (1987) 1.47
Ophthalmic manifestations of Smith-Magenis syndrome. Ophthalmology (1996) 1.47
Isolation and characterization of heparin from human lung. J Clin Invest (1979) 1.46
Acquired arterial macroaneurysms of the retina. Br J Ophthalmol (1976) 1.46
Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis. Proc Natl Acad Sci U S A (1981) 1.45
DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron (1991) 1.45
Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique. J Pharmacol Exp Ther (1987) 1.45
Formation of slow-reacting substance of anaphylaxis in human lung tissue and cells before release. J Exp Med (1974) 1.44
Axons regulate Schwann cell expression of the POU transcription factor SCIP. J Neurosci (1994) 1.42
Cavernous haemangioma of the retina and optic disc. A report of three cases and a review of the literature. Br J Ophthalmol (1975) 1.42
Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4). Hum Genet (2001) 1.41
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. Eur J Neurol (2001) 1.41
Molecular analysis of the 18q- syndrome--and correlation with phenotype. Am J Hum Genet (1993) 1.40
Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment. Am J Hum Genet (1988) 1.40
Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet (1984) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39